Analysis of Intestinal and Nasopharyngeal Microbiota of Children with Meningococcemia in Pediatric Intensive Care Unit: INMACS-PICU Study
Gurkan Bozan,
Vicente Pérez-Brocal,
Kaan Aslan,
Eylem Kiral,
Esra Sevketoglu,
Mutlu Uysal Yazici,
Ebru Azapagasi,
Tanil Kendirli,
Serhat Emeksiz,
Oguz Dursun,
Dincer Yildizdas,
Ayse Berna Anil,
Nihal Akcay,
Hasan Serdar Kihtir,
Merve Havan,
Nazan Ulgen Tekerek,
Faruk Ekinci,
Omer Kilic,
Andres Moya,
Ener Cagri Dinleyici
Affiliations
Gurkan Bozan
Pediatric Intensive Care Unit, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Turkey
Vicente Pérez-Brocal
Area of Genomics and Health, Foundation for the Promotion of Sanitary and Biomedical Research of Valencia Region (FISABIO-Public Health), 46020 Valencia, Spain
Kaan Aslan
Department of Pediatrics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Turkey
Eylem Kiral
Pediatric Intensive Care Unit, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Turkey
Esra Sevketoglu
Pediatric Intensive Care Unit, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul 34147, Turkey
Mutlu Uysal Yazici
Pediatric Intensive Care Unit, Faculty of Medicine, Gazi University, Ankara 06500, Turkey
Ebru Azapagasi
Pediatric Intensive Care Unit, Faculty of Medicine, Gazi University, Ankara 06500, Turkey
Tanil Kendirli
Pediatric Intensive Care Unit, Faculty of Medicine, Ankara University, Ankara 06590, Turkey
Serhat Emeksiz
Pediatric Intensive Care Unit, Ankara City Hospital, Ankara 06800, Turkey
Oguz Dursun
Pediatric Intensive Care Unit, Faculty of Medicine, Akdeniz University, Antalya 07070, Turkey
Dincer Yildizdas
Pediatric Intensive Care Unit, Faculty of Medicine, Cukurova University, Adana 01790, Turkey
Ayse Berna Anil
Pediatric Intensive Care Unit, Faculty of Medicine, Izmir Katip Celebi University, Izmir 35620, Turkey
Nihal Akcay
Pediatric Intensive Care Unit, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul 34147, Turkey
Hasan Serdar Kihtir
Department of Pediatric Critical Care, Antalya Training and Research Hospital, University of Health Sciences, Antalya 07100, Turkey
Merve Havan
Pediatric Intensive Care Unit, Faculty of Medicine, Ankara University, Ankara 06590, Turkey
Nazan Ulgen Tekerek
Pediatric Intensive Care Unit, Faculty of Medicine, Akdeniz University, Antalya 07070, Turkey
Faruk Ekinci
Pediatric Intensive Care Unit, Faculty of Medicine, Cukurova University, Adana 01790, Turkey
Omer Kilic
Division of Pediatric Infectious Diseases, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Turkey
Andres Moya
Area of Genomics and Health, Foundation for the Promotion of Sanitary and Biomedical Research of Valencia Region (FISABIO-Public Health), 46020 Valencia, Spain
Ener Cagri Dinleyici
Pediatric Intensive Care Unit, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Turkey
Microbiota composition might play a role in the pathophysiology and course of sepsis, and understanding its dynamics is of clinical interest. Invasive meningococcal disease (IMD) is an important cause of community-acquired serious infection, and there is no information regarding microbiota composition in children with meningococcemia. In this study, we aimed to evaluate the intestinal and nasopharyngeal microbiota composition of children with IMD. Materials and Methods: In this prospective, multi-center study, 10 children with meningococcemia and 10 age-matched healthy controls were included. Nasopharyngeal and fecal samples were obtained at admission to the intensive care unit and on the tenth day of their hospital stay. The V3 and V4 regions of the 16S rRNA gene were amplified following the 16S Metagenomic Sequencing Library Preparation. Results: Regarding the alpha diversity on the day of admission and on the tenth day at the PICU, the Shannon index was significantly lower in the IMD group compared to the control group (p = 0.002 at admission and p = 0.001, on the tenth day of PICU). A statistical difference in the stool samples was found between the IMD group at Day 0 vs. the controls in the results of the Bray–Curtis and Jaccard analyses (p = 0.005 and p = 0.001, respectively). There were differences in the intestinal microbiota composition between the children with IMD at admission and Day 10 and the healthy controls. Regarding the nasopharyngeal microbiota analysis, in the children with IMD at admission, at the genus level, Neisseria was significantly more abundant compared to the healthy children (p Moraxella and Neisseria were decreased compared to the healthy children. In the children with IMD on Day 0, for paired samples, Moraxella, Neisseria, and Haemophilus were significantly more abundant compared to the children with IMD at Day 10. In the children with IMD at Day 10, the Moraxella and Neisseria genera were decreased, and 20 different genera were more abundant compared to Day 0. Conclusions: We first found alterations in the intestinal and nasopharyngeal microbiota composition in the children with IMD. The infection itself or the other care interventions also caused changes to the microbiota composition during the follow-up period. Understanding the interaction of microbiota with pathogens, e.g., N. meningitidis, could give us the opportunity to understand the disease’s dynamics.